hfpef semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials Semaglutide in HFpEF across obesity
Description
Gao Z, Tabernacki T, Dorney I, et al
PMID 23397029
Temperature monitoring is important throughout the storage process
The set point theory remains a hypothesis as the molecular mechanisms behind it continue to be ambiguous
Wegovy is for long-term weight management
These results match the efficacy of injectable PCSK9 inhibitors like Amgen's Repatha, Regeneron's Praluent, and Novartis' Leqviobut with critical advantages
